Hypolipidemic Activity of Olive Oil (Olea europaea) against High Fat Diet-Induced Nonalcoholic Fatty Liver Disease (NAFLD) in Mice


Aim: The aim of the present study is to access the effect of olive oil supplementation against high fat diet induced fatty liver disease in mice. Methods: Mice were divided into five groups: Group I (normal diet), Group II (high fat diet), Group III (olive oil), Group IV and V (High Fat Diet along with olive oil). All mice were fed for 16 weeks with weight measurements every 2 weeks and then sacrificed. Biochemical analysis of blood samples was done and mice livers were histologically examined. Results: Group II mice showed significant increase in body weight as compared with Group I (p < 0.05). Group IV and V mice were significantly (p < 0.05) reduced in body weight as compared with Group II. Olive oil groups had significantly decreased triglyceride and low density lipoprotein levels as compared with Group II whereas high density lipoprotein levels were significantly increased (p < 0.05). The liver enzymes were significantly increased in Group II as compared with other groups (p < 0.05). Liver histopathology revealed drastically increased lipid droplets in Group II mice as compared with Group IV & V. Conclusion: Olive oil causes weight reduction, decreases the serum triglycerides, normalizes the liver enzymes and significantly reduces the accumulation of fat in liver. Therefore, olive oil may represent a potential therapeutic alternative for NAFLD and other fatty diseases.

Share and Cite:

Wani, F. , Albahrawy, A. and Rahiman, S. (2015) Hypolipidemic Activity of Olive Oil (Olea europaea) against High Fat Diet-Induced Nonalcoholic Fatty Liver Disease (NAFLD) in Mice. Open Journal of Pathology, 5, 73-83. doi: 10.4236/ojpathology.2015.53011.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Hamelet, J., Demuth, K., Paul, J.L., Delabar, J.M. and Janel, N. (2007) Hyperhomocysteinemia due to Cystathionine Beta Synthase Deficiency Induces Dysregulation of Genes Involved in Hepatic Lipid Homeostasis in Mice. Journal of Hepatology, 46, 151-159.
[2] Shahani, A. and Handa, S.S. (1995) Hepatoprotective Activity of Apium graveolens and Hygrophill aauriculata against Paracetamol and Thioacetamide Intoxicationin in Rats. Journal of Ethnophar-macology, 49, 119-126. http://dx.doi.org/10.1016/0378-8741(95)01291-5
[3] Adams, L.A. and Angulo, P. (2005) Recent Concepts in Non-Alcoholic Fatty Liver Disease. Diabetic Medicine, 22, 1129-1133. http://dx.doi.org/10.1111/j.1464-5491.2005.01748.x
[4] SuriyavathanaVedanarayanan, M. and Krishnan, N. (2011) Ayurvedic Formulation of Liv-Pro-08 Reduces Nonalcoholic Fatty Liver Disease in Rats Fed with High-fat Diet. Journal of Acupuncture and Meridian Studies, 4, 236-241. http://dx.doi.org/10.1016/j.jams.2011.09.014
[5] Angulo, P. (2002) Nonalcoholic Fatty Liver Disease. The New England Journal of Medicine, 346, 1221-1231. http://dx.doi.org/10.1056/NEJMra011775
[6] Clark, J.M. (2002) Nonalcoholic Fatty Liver Disease. Gastroenterology, 122, 1649-1657.
[7] Grattagliano, I., Palmieri, V.O., Portincasa, P., Moschetta, A. and Palasciano, G. (2008) Oxidative Stress-Induced Risk Factors Associated with the Metabolic Syndrome: A Unifying Hypothesis. The Journal of Nutritional Biochemistry, 19, 491-504. http://dx.doi.org/10.1016/j.jnutbio.2007.06.011
[8] Videla, L.A., Rodrigo, R., Araya, J. and Ponichik, J. (2006) Insulin Resistance and Oxidative Stress Interdependency in Non-Alcoholic Fatty Liver Disease. Trends in Molecular Medicine, 12, 555-558.
[9] Adams, L.A., Lymp, J.F., St. Sauver, J., et al. (2005) The Natural History of Non-Alcoholic Fatty Liver Disease: A Population-Based Cohort Study. Gastroenterology, 129, 113-121.
[10] Fon Tacer, K. and Rozman, D. (2011) Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation. Journal of Lipids, 2011, 1-14. http://dx.doi.org/10.1155/2011/783976
[11] Musunuru, K. (2010) Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention. Lipids, 45, 907-914. http://dx.doi.org/10.1007/s11745-010-3408-1
[12] Knoops, K.T.B., de Groot, L.C.P., Kromhout, D., Perrin, A.E., Moreiras-Varela, O., Menotti, A., et al. (2004) Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality in Elderly European Men and Women. JAMA, 292, 1433-1446. http://dx.doi.org/10.1001/jama.292.12.1433
[13] Lou-Bonafonte, J., Arnal, C., Navarro, M. and Osada, J. (2012) Efficacy of Bioactive Compounds from Extra Virgin Olive Oil to Modulate Atherosclerosis Development. Molecular Nutrition & Food Research, 56, 1043-1057. http://dx.doi.org/10.1002/mnfr.201100668
[14] Kok, F.J. and Kromhout, D. (2012) Atherosclerosis-Epidemiological Studies on the Health Effects of a Mediterranean diet. European Journal of Nutrition, 43, I/2-I/5.
[15] Stark, A.H. and Madar, Z. (2002) Olive Oil as a Functional Food: Epidemiology and Nutritional Approaches. Nutrition Reviews, 60, 170-176. http://dx.doi.org/10.1301/002966402320243250
[16] Benavente-Garcia, O., Castillo, J., Lorente, J. and Alcaraz, M. (2002) Radioprotective Effects in Vivo of Phenolics Extracted from Olea europaea L. Leaves against X-Ray Induced Chromosomal Damage: Comparative Study versus Several Flavonoids and Sulfur-Containing Compounds. Journal of Medicinal Food, 5, 125-135. http://dx.doi.org/10.1089/10966200260398152
[17] Khayyal, M.T., El-Ghazaly, M.A., Abdallah, D.M., Nassar, N.N., Okpanyi, S.N. and Kreuter, M.H. (2002) Blood Pressure Lowering Effect of an Olive Leaf Extract (Olea europaea) in L-NAME Induced Hypertension in Rates. Arzneimittel-Forschung, 52, 797-802.
[18] Komaki, F., Yamaguchi, E., Maru, S., Kinoshita, M., Kakehi, K., Ohta, Y., et al. (2003) Identification of Anti-Alpha-Amylase Components from Olive Leaf Extracts. Food Science and Technology Research, 9, 35-39. http://dx.doi.org/10.3136/fstr.9.35
[19] Bouaziz, M. and Sayadi, S. (2005) Isolation and Evaluation of Antioxidants from Leaves of a Tunisian Cultivar Olive Tree. European Journal of Lipid Science and Technology, 107, 497-504.
[20] Poudyal, H., Campbell, F. and Brown, L. (2010) Olive Leaf Extract Attenuates Cardiac, Hepatic and Metabolic Changes in High Carbohydrate-, High Fat-Fed Rats. The Journal of Nutrition, 140, 946-953.
[21] Wani, F.A., Rahiman, S. and Tantry, B.A. (2015) Evaluation of Anti Asthmatic Effect of Extra Virgin Olive Oil (Olea europea) Against Milk Induced Leukocytosis and Eosinophilia. Advances in Bior-esearch, 6, 15-18.
[22] López-Miranda, J., Pérez-Jiménez, F., Ros, E., De Caterina, R., Badimón, L., Covas, M.I., et al. (2010) Olive Oil and Health: Summary of the II International Conference on Olive Oil and Health Consensus Report, Jaen and Cordoba (Spain) 2008. Nutrition, Metabolism and Cardiovascular Diseases, 20, 284-294. http://dx.doi.org/10.1016/j.numecd.2009.12.007
[23] Gimeno, E., Fitó, M., Lamuela-Raventós, R.M., Castellote, A.I., Covas, M., Farré, M., et al. (2002) Effect of Ingestion of Virgin Olive Oil on Human Low-Density Lipoprotein Composition. European Journal of Clinical Nutrition, 56, 114-120. http://dx.doi.org/10.1038/sj.ejcn.1601293
[24] Gorinstein, S., Leontowicz, H., Lojek, A., Leontowicz, M., Ciz, M., Krzeminski, R., et al. (2002) Olive Oils Improve Lipid Metabolism and Increase Antioxidant Potential in Rats Fed Diets Containing Cholesterol. Journal of Agricultural and Food Chemistry, 50, 6102-6108.
[25] de la Puerta, R., Ruiz Gutierrez, V. and Hoult, J.R. (1999) Inhibition of Leukocyte 5-Lipoxygenase by Phenolics from Virgin Olive Oil. Biochemical Pharmacology, 57, 445-449.
[26] Petroni, A., Blasevich, M., Salami, M., Papini, N., Montedoro, G.F. and Galli, C. (1995) Inhibition of Platelet Aggregation and Eicosanoid Production by Phenolic Components of Olive Oil. Thrombosis Research, 78, 151-160. http://dx.doi.org/10.1016/0049-3848(95)00043-7
[27] Mukundh, N.B., Muralidharan, P. and Balamurugan, G. (2008) Anti Hyperlipidemic Activity of Pedalium murex (Linn.) Fruits on High Fat Diet Fed Rats. International Journal of Pharmacology, 4, 310-313.
[28] Lorke, D. (1983) A New Approach to Practical Acute Toxicity Testing. Archives of Toxicology, 53, 275-289. http://dx.doi.org/10.1007/BF01234480
[29] Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., et al. (2005) The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease. Annals of Internal Medicine, 143, 722-728. http://dx.doi.org/10.7326/0003-4819-143-10-200511150-00009
[30] Elahi, R.K. (2012) Preventive Effects of Turmeric (Curcuma longa Linn.) Powder on Hepatic Steatosis in the Rats Fed with High Fat Diet. Life Science Journal, 9, 5462-5468.
[31] Pascos, P. and Paletas, N. (2009) Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Hippokrata, 1, 9-19.
[32] Asari, J.A., Sayyed, M. and Sayyed, F. (2011) Management of Non-Alcoholic Fatty Liver Disease and Their Complications. International Journal of Pharmaceutics, 5, 579-588.
[33] Xiao, J., Guo, R., Fung, M.L., Liong, E.C. and Tipoe, G.L. (2013) Therapeutic Approaches to Non-Alcoholic Fatty Liver Disease: Past Achievements and Future Challenges. Hepatobiliary & Pancreatic Diseases International, 12, 125-135. http://dx.doi.org/10.1016/S1499-3872(13)60021-1
[34] Tan, Y., Lao, W., Xiao, L., Wang, Z., Xiao, W., Kamal, M.A., et al. (2013) Managing the Combination of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese Herbal Extracts in High-Fat-Diet Fed Rats. Evidence-Based Complementary and Alternative Medicine, 2013, Article ID: 306738.
[35] Thoma, C., Day, P. and Trenell, M.I. (2012) Lifestyle Interventions for the Treatment of Non-Alcoholic Fatty Liver Disease in Adults: Asystematic Review. Journal of Hepatology, 56, 255-266.
[36] Adams, L.A. and Angulo, P. (2006) Treatment of Non-Alcoholic Fatty Liver Disease. Postgraduate Medical Journal, 82, 315-322. http://dx.doi.org/10.1136/pgmj.2005.042200
[37] Han, L.K., Kimura, Y. and Okuda, H. (1999) Reduction in Fat Storage during Chitin-Chitosan Treatment in Mice Fed a High Fat Diet. International Journal of Obesity, 23, 174-179.
[38] Han, L.K., Sumiyoshi, M., Takida, T., Chihara, H., Nishikiori, T., Tsujita, T., et al. (2000) Inhibitory Effects of Chondroitin Sulfate Prepared from Salmon Nasal Cartilage on Fat Storage on Mice Fed a High Fat Diet. International Journal of Obesity, 24, 1131-1138.
[39] Bes-Rastrollo, M., Sánchez-Villegas, A., de la Fuente, C., de Irala, J., Martínez, J.A. and Martínez-González, M.A. (2006) Olive Oil Consumption and Weight Change: The SUN Prospective Cohort Study. Lipids, 41, 249-256. http://dx.doi.org/10.1007/s11745-006-5094-6
[40] Pérez-Martínez, P., García-Ríos, A., Delgado-Lista, J., Pérez-Jiménez, F. and López-Miranda, J. (2011) Mediterranean Diet Rich in Olive Oil and Obesity, Metabolic Syndrome and Diabetes Mellitus. Current Pharmaceutical Design, 17, 769-777. http://dx.doi.org/10.2174/138161211795428948
[41] Keys, A., Menotti, A., Karvonen, M.J., Aravanis, C., Blackburn, H., Buzina, R., et al. (1986) The Diet and 15-Year Death Rate in the Seven Countries Study. American Journal of Epidemiology, 124, 903-915.
[42] Jones, P.J.H., Demonty, I., Chan, Y.M., Herzog, Y. and Pelled, D. (2007) Fish-Oil Esters of Plant Sterols Differ from Vegetable-Oil Sterol Esters in Triglycerides Lowering, Carotenoid Bioavailability and Impact on Plasminogen Activator Inhibitor-1(PAI-1) Concentrations in Hypercholesterolemic Subjects. Lipids in Health and Disease, 6, 28-37. http://dx.doi.org/10.1186/1476-511X-6-28
[43] Alhazza, I.M. (2007) Antioxidant and Hypolipidemic Effects of Olive Oil in Normal and Diabetic Male Rats. Saudi Journal of Biological Sciences, 14, 69-74.
[44] Paoli, A., Cenci, L. and Grimaldi, K.A. (2011) Effect of Ketogenic Mediterranean Diet with Phyto Extracts and Low Carbohydrates/High Protein Meals on Weight, Cardiovascular Risk Factors, Body Composition and Diet Compliance in Italian Council Employees. Nutrition Journal, 10, 112-120. http://dx.doi.org/10.1186/1475-2891-10-112
[45] Donnelly, K.L., Smith, C.I., Schwarzenbirg, S.L., Jessurun, J., Boldt, M.D. and Parks, E.J. (2005) Sources of Fatty Acids Stored in Liver and Secreted via Lipoproteins in Patients with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Investigation, 115, 1343-1351.
[46] Louka, M.L., Habib, H.Z., Youssef, M.H.M. and Nassef, N.A.H. (2012) Effect of Olive Oil Supplementation on PAI-1 Expression in Old Rats. The Journal of American Science, 8, 317-321.
[47] Simon-Giavaritti, K.A., Giavarotti, L., Gomes, L.F., Lima, A.F., Veridin, A.M., Garcia, E.A., et al. (2002) Enhancement of Lindane-Induced Liver Oxidative Stress and Hepatotoxicity by Thyroid Hormone Is Reduced by Gadolinum Chloride. Free Radical Research, 36, 1033-1039.
[48] Amin, A. and Hamza, A.A. (2005) Oxidative Stress Mediates Drug-Induced Hepatotoxicity in Rats a Possible Role of DNA Fragmentation. Toxicology, 208, 367-375.
[49] Falck-Ytter, Y., Younossi, Z.M., Marchesini, G. and McCullough, A.J. (2001) Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes. Seminars in Liver Disease, 21, 17-26.
[50] Al-Rawi, M. and Ali, A. (2010) Efficacy of Olive Oil Diet on the Histopathological Changes Induced in Hypercholesterolemic Rat. Egyptian Academic Journal of Biological Sciences, 2, 1-9.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.